AEMD - エスロン・メディカル （Aethlon Medical Inc.） エスロン・メディカルAEMDのチャート
AEMDの企業情報
| symbol | AEMD |
|---|---|
| 会社名 | Aethlon Medical Inc （エスロン・メディカル） |
| 分野（sector） | Capital Goods 資本財（工業製品） |
| 産業（industry） | Biotechnology: Laboratory Analytical Instruments |
| 業種 | 医療機器_医療用品_ディストリビュ―タ― 医療関連（Health Care） |
| 概要 | 事業概要 Aethlon Medical Inc. is a medical device company focused on creating devices for cancer infectious disease and other life-threatening conditions. The Company operates through two segments: Aethlon which represents its therapeutic business activities and ESI which represents its diagnostic business activities. The Company's lead product is the Aethlon Hemopurifier which is a device that selectively targets the elimination of circulating viruses and tumor-secreted exosomes that promote cancer progression. The Aethlon Hemopurifier sheds glycoproteins to treat infectious viral pathogens. In oncology indications the Hemopurifier targets the removal of circulating exosomes which are released to promote cancer progression and to seed the spread of metastasis. Through its subsidiary Exosome Sciences Inc. (Exosome) the Company is also developing exosome-based product candidates to diagnose and monitor neurological disorders and cancer. エスロン・メディカルは米国の医療機器メ―カ―。がんや感染症疾患治療用ろ過装置の開発、製造に従事する。同社の「エスロン・キ―モピュ―リファイア」はHIVやC型肝炎ウイルスなどのウイルス性病原体治療用血液浄化フィルタ―で、患者の血液や腹水からエキソソ―ムを除去することが可能。また、乳がん用や敗血症用フィルタ―も扱う。本社はカリフォルニア州。 |
| 本社所在地 | 9635 Granite Ridge Drive Suite 100 San Diego CA 92123 USA |
| 代表者氏名 | Rodney S. Kenley ロドニー・S・ケンリー |
| 代表者役職名 | President Director 社長 |
| 電話番号 | +1 858-459-7800 |
| 設立年月日 | 33329 |
| 市場名 | NASDAQ Small Cap |
| ipoyear | ―年 |
| 従業員数 | 6人 |
| url | www.aethlonmedical.com |
| nasdaq_url | https://www.nasdaq.com/symbol/aemd |
| adr_tso | ― |
| EBITDA | EBITDA（百万ドル） -4.73369 |
| 終値（lastsale） | 1.07 |
| 時価総額（marketcap） | 19044125.36 |
| 時価総額 | 時価総額（百万ドル） 19.75606 |
| 売上高 | 売上高（百万ドル） 0.29925 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 14.50460 |
| 当期純利益 | 当期純利益（百万ドル） -4.98401 |
| 決算概要 | 決算概要 BRIEF: For the three months ended 30 June 2018 Aethlon Medical Inc. revenues increased from $0K to $150K. Net loss decreased 38% to $1.1M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Lower net loss reflects Loss on debt extinguishment decrease from $377K (expense) to $0K Amortization of Note Discounts decrease of 80% to $30K (expense). |
AEMDのテクニカル分析
AEMDのニュース
Aethlon Medical News Alert: Why AEMD Stock Is Rocketing Higher Today 2020/12/16 15:07:59 InvestorPlace
Aethlon Medical (AEMD) news for Wednesday concerning the progress in an EFS for one of its medical devices has AEMD stock soaring higher.
Worldwide Companion Diagnostic Industry to 2025 - Featuring Abbott Diagnostics, AccuraGen and Aethlon Medical Among Others - ResearchAndMarkets.com 2020/11/17 13:28:00 Business Wire
DUBLIN--(BUSINESS WIRE)--The "Companion Diagnostic Markets - the Future of Diagnostics, by Funding Source and Application with Customized Forecasting/Analysis, COVID-19 Updates, and Executive and Consultant Guides 2021-2025" report has been added to ResearchAndMarkets.com's offering. Companion Diagnostics are poised to revolutionize the diagnostics industry. The market is finally moving out of the lab and into the clinic. Oncology, especially immune-oncology is leading the way. And the FDA is h
Aethlon Medical Announces First Quarter Financial Results and Provides Corporate Update 2020/08/11 16:15:00 Benzinga
SAN DIEGO, Aug. 11, 2020 /PRNewswire/ -- Aethlon Medical, Inc. (NASDAQ:AEMD), a medical device technology company focused on developing products to diagnose …
BRIEF-Aethlon Announces FDA Approval Of IDE Supplement For COVID-19 Patients 2020/06/18 13:36:17 Reuters
Aethlon Medical Inc:
AEMD shares suspended 2020/02/07 15:56:55 Yahoo Finance
Aethlon Medical, Inc. shares were suspended on Friday after it was found that the company was falsifying information about a coronavirus cure. Yahoo Finance’s Jared Blikre breaks down the details.
Aethlon Medical Announces First Quarter Financial Results and Provides Corporate Update 2020/08/11 16:15:00 Benzinga
SAN DIEGO, Aug. 11, 2020 /PRNewswire/ -- Aethlon Medical, Inc. (NASDAQ:AEMD), a medical device technology company focused on developing products to diagnose …
BRIEF-Aethlon Announces FDA Approval Of IDE Supplement For COVID-19 Patients 2020/06/18 13:36:17 Reuters
Aethlon Medical Inc:
AEMD shares suspended 2020/02/07 15:56:55 Yahoo Finance
Aethlon Medical, Inc. shares were suspended on Friday after it was found that the company was falsifying information about a coronavirus cure. Yahoo Finance’s Jared Blikre breaks down the details.
The Zacks Analyst Blog Highlights: Novavax, NanoViricides, Aethlon Medical and Oncolytics Biotech 2020/01/23 14:13:00 Zacks Investment Research
The Zacks Analyst Blog Highlights: Novavax, NanoViricides, Aethlon Medical and Oncolytics Biotech
The Daily Biotech Pulse: Axovant Surges On Gene Therapy Study Results, FDA Approves Merck's Ebola Vaccine, Abeona Announces Offering 2019/12/20 13:12:05 Benzinga
The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs Dec. 19.) Acceleron Pharma Inc (NASDAQ: XLRN ) Ardelyx Inc (NASDAQ: ARDX ) AstraZeneca plc (NYSE: AZN ) Axsome Therapeutics Inc (NASDAQ: AXSM ) (priced its 2-million-share common stock offering at $87 per share) Clearside Biomedical Inc (NASDAQ: CLSD ) Cortexyme Inc (NASDAQ: CRTX ) Cue Biopharma Inc (NASDAQ: CUE ) Exagen Inc (NASDAQ: XGN ) Globus Medical Inc (NYSE: GMED ) Horizon Therapeutics PLC (NASDAQ: HZNP ) HEALTH SCIENCES/SH (NASDAQ: IMVT ) (The acquisition vehicle announced merger with Immuvant, a clinical-stage biopharma company focusing on autoimmune disorders) IVERIC bio Inc (NASDAQ: ISEE ) Johnson & Johnson (NYSE: JNJ ) (Barclays upgraded shares to Overweight) The Medicines Company (NASDAQ: MDCO ) Merck & Co., Inc. (NYSE: MRK ) Mirum Pharmaceuticals Inc (NASDAQ: MIRM ) Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA ) Monopar Therapeutics Inc. (NASDAQ: MNPR ) (Went public Thursday) Myokardia Inc (NASDAQ: MYOK ) NeoGenomics, Inc. (NASDAQ: NEO ) Novan Inc (NASDAQ: NOVN ) Oramed Pharmaceuticals, Inc. (NASDAQ: ORMP ) Principia Biopharma Inc (NASDAQ: PRNB ) Quest Diagnostics Inc (NYSE: DGX ) Recro Pharma Inc (NASDAQ: REPH ) Sanofi SA (NASDAQ: SNY ) SpringWorks Therapeutics Inc (NASDAQ: SWTX ) Down In The Dumps (Biotech stocks that hit 52-week lows Dec. 19.) Aethlon Medical, Inc. (NASDAQ: AEMD ) Anixa Biosciences Inc (NASDAQ: ANIX ) Aridis Pharmaceuticals Inc (NASDAQ: ARDS ) China SXT Pharmaceuticals Inc (NASDAQ: SXTC ) Correvio Pharma Corp (NASDAQ: …
Aethlon Medical Announces First Quarter Financial Results and Provides Corporate Update 2020/08/11 16:15:00 Benzinga
SAN DIEGO, Aug. 11, 2020 /PRNewswire/ -- Aethlon Medical, Inc. (NASDAQ:AEMD), a medical device technology company focused on developing products to diagnose …
BRIEF-Aethlon Announces FDA Approval Of IDE Supplement For COVID-19 Patients 2020/06/18 13:36:17 Reuters
Aethlon Medical Inc:
AEMD shares suspended 2020/02/07 15:56:55 Yahoo Finance
Aethlon Medical, Inc. shares were suspended on Friday after it was found that the company was falsifying information about a coronavirus cure. Yahoo Finance’s Jared Blikre breaks down the details.
The Zacks Analyst Blog Highlights: Novavax, NanoViricides, Aethlon Medical and Oncolytics Biotech 2020/01/23 14:13:00 Zacks Investment Research
The Zacks Analyst Blog Highlights: Novavax, NanoViricides, Aethlon Medical and Oncolytics Biotech
The Daily Biotech Pulse: Axovant Surges On Gene Therapy Study Results, FDA Approves Merck's Ebola Vaccine, Abeona Announces Offering 2019/12/20 13:12:05 Benzinga
The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs Dec. 19.) Acceleron Pharma Inc (NASDAQ: XLRN ) Ardelyx Inc (NASDAQ: ARDX ) AstraZeneca plc (NYSE: AZN ) Axsome Therapeutics Inc (NASDAQ: AXSM ) (priced its 2-million-share common stock offering at $87 per share) Clearside Biomedical Inc (NASDAQ: CLSD ) Cortexyme Inc (NASDAQ: CRTX ) Cue Biopharma Inc (NASDAQ: CUE ) Exagen Inc (NASDAQ: XGN ) Globus Medical Inc (NYSE: GMED ) Horizon Therapeutics PLC (NASDAQ: HZNP ) HEALTH SCIENCES/SH (NASDAQ: IMVT ) (The acquisition vehicle announced merger with Immuvant, a clinical-stage biopharma company focusing on autoimmune disorders) IVERIC bio Inc (NASDAQ: ISEE ) Johnson & Johnson (NYSE: JNJ ) (Barclays upgraded shares to Overweight) The Medicines Company (NASDAQ: MDCO ) Merck & Co., Inc. (NYSE: MRK ) Mirum Pharmaceuticals Inc (NASDAQ: MIRM ) Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA ) Monopar Therapeutics Inc. (NASDAQ: MNPR ) (Went public Thursday) Myokardia Inc (NASDAQ: MYOK ) NeoGenomics, Inc. (NASDAQ: NEO ) Novan Inc (NASDAQ: NOVN ) Oramed Pharmaceuticals, Inc. (NASDAQ: ORMP ) Principia Biopharma Inc (NASDAQ: PRNB ) Quest Diagnostics Inc (NYSE: DGX ) Recro Pharma Inc (NASDAQ: REPH ) Sanofi SA (NASDAQ: SNY ) SpringWorks Therapeutics Inc (NASDAQ: SWTX ) Down In The Dumps (Biotech stocks that hit 52-week lows Dec. 19.) Aethlon Medical, Inc. (NASDAQ: AEMD ) Anixa Biosciences Inc (NASDAQ: ANIX ) Aridis Pharmaceuticals Inc (NASDAQ: ARDS ) China SXT Pharmaceuticals Inc (NASDAQ: SXTC ) Correvio Pharma Corp (NASDAQ: …